The latest from Amide
Picking a peptide supplier for a single catalogue sequence is low stakes. If it goes wrong, you reorder. Committing to one for a discovery...
Every drug discovery program built on peptide therapeutics eventually runs into the same wall: you need a compound you can’t make in-house, on a...
Every peptide drug design program eventually hits the same fork: the linear sequence won’t get you the potency, stability, or selectivity you...
Amide is accepting customers looking for a reliable source for hard-to-obtain peptides.